These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 36719471)
41. Associations between red blood cell count and metabolic dysfunction-associated fatty liver disease(MAFLD). Dai X; Zhou G; Xu L PLoS One; 2022; 17(12):e0279274. PubMed ID: 36574367 [TBL] [Abstract][Full Text] [Related]
42. Associations of metal mixtures with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2003-2018. Xie Z; Aimuzi R; Si M; Qu Y; Jiang Y Front Public Health; 2023; 11():1133194. PubMed ID: 36950101 [TBL] [Abstract][Full Text] [Related]
43. MAFLD and risk of CKD. Sun DQ; Jin Y; Wang TY; Zheng KI; Rios RS; Zhang HY; Targher G; Byrne CD; Yuan WJ; Zheng MH Metabolism; 2021 Feb; 115():154433. PubMed ID: 33212070 [TBL] [Abstract][Full Text] [Related]
44. Relationship Between Non-alcoholic Fatty Liver Disease and Decreased Bone Mineral Density: A Retrospective Cohort Study in Korea. Sung J; Ryu S; Song YM; Cheong HK J Prev Med Public Health; 2020 Sep; 53(5):342-352. PubMed ID: 33070506 [TBL] [Abstract][Full Text] [Related]
45. Influence of cardiovascular disease risk factors on the relationship between low bone mineral density and type 2 diabetes mellitus in a multiethnic US population of women and men: a cross-sectional study. Broussard DL; Magnus JH Gend Med; 2008 Sep; 5(3):229-38. PubMed ID: 18727989 [TBL] [Abstract][Full Text] [Related]
46. Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study. Chen YL; Li H; Li S; Xu Z; Tian S; Wu J; Liang XY; Li X; Liu ZL; Xiao J; Wei JY; Ma CY; Wu KN; Ran L; Kong LQ BMC Gastroenterol; 2021 May; 21(1):212. PubMed ID: 33971822 [TBL] [Abstract][Full Text] [Related]
47. Prediction of MAFLD and NAFLD using different screening indexes: A cross-sectional study in U.S. adults. Peng H; Pan L; Ran S; Wang M; Huang S; Zhao M; Cao Z; Yao Z; Xu L; Yang Q; Lv W Front Endocrinol (Lausanne); 2023; 14():1083032. PubMed ID: 36742412 [TBL] [Abstract][Full Text] [Related]
48. Association between carotenoid intake and metabolic dysfunction-associated fatty liver disease among US adults: A cross-sectional study. Zhang H; Li L; Jia L; Liu J Medicine (Baltimore); 2023 Dec; 102(51):e36658. PubMed ID: 38134087 [TBL] [Abstract][Full Text] [Related]
49. Associations between serum vitamin E concentration and bone mineral density in the US elderly population. Zhang J; Hu X; Zhang J Osteoporos Int; 2017 Apr; 28(4):1245-1253. PubMed ID: 27909782 [TBL] [Abstract][Full Text] [Related]
50. Association of bone mineral density and diabetic retinopathy in diabetic subjects: the 2008-2011 Korea National Health and Nutrition Examination Survey. Lim Y; Chun S; Lee JH; Baek KH; Lee WK; Yim HW; Kang MI Osteoporos Int; 2016 Jul; 27(7):2249-2257. PubMed ID: 26883444 [TBL] [Abstract][Full Text] [Related]
51. Sex differences in the association between stroke and bone mineral density in elderly Koreans: The Korean National Health and Nutrition Examination Survey, 2008-2010. Lee JE; Jeon HR; Park JK; Han KD; Kim JH; Yoon J; Park SW; Kim YH; Cho KH Maturitas; 2017 Jan; 95():1-5. PubMed ID: 27889047 [TBL] [Abstract][Full Text] [Related]
52. Comparison of MAFLD and NAFLD diagnostic criteria in real world. Lin S; Huang J; Wang M; Kumar R; Liu Y; Liu S; Wu Y; Wang X; Zhu Y Liver Int; 2020 Sep; 40(9):2082-2089. PubMed ID: 32478487 [TBL] [Abstract][Full Text] [Related]
53. Association of the composite dietary antioxidant index with bone mineral density in the United States general population: data from NHANES 2005-2010. Han H; Chen S; Wang X; Jin J; Li X; Li Z J Bone Miner Metab; 2023 Sep; 41(5):631-641. PubMed ID: 37291468 [TBL] [Abstract][Full Text] [Related]
54. Using new indices to predict metabolism dysfunction-associated fatty liver disease (MAFLD): analysis of the national health and nutrition examination survey database. Li XM; Liu SL; He YJ; Shu JC BMC Gastroenterol; 2024 Mar; 24(1):109. PubMed ID: 38491451 [TBL] [Abstract][Full Text] [Related]
55. Association of aspirin with all-cause and cardiocerebrovascular mortality in patients with metabolic associated fatty liver disease. Chen Z; Chen M; Zeng P; Yang X; Li Q Scand J Gastroenterol; 2023; 58(8):908-914. PubMed ID: 36799202 [TBL] [Abstract][Full Text] [Related]
56. Nocturnal sleep duration and bone mineral density: a cross-sectional study of the National Health and Nutrition Examination Survey (NHANES) 2007-2014. Tang Y; Liu J; Feng Z; Liu Z; Wang S; Xia Y; Geng B BMC Endocr Disord; 2022 Dec; 22(1):333. PubMed ID: 36575443 [TBL] [Abstract][Full Text] [Related]
57. Association between low bone mineral density and hearing impairment in postmenopausal women: the Korean National Health and Nutrition Examination Survey. Lee SS; Han KD; Joo YH BMJ Open; 2018 Jan; 8(1):e018763. PubMed ID: 29371277 [TBL] [Abstract][Full Text] [Related]
58. Association between alcohol consumption and bone mineral density in elderly Korean men and women. Cho Y; Choi S; Kim K; Lee G; Park SM Arch Osteoporos; 2018 Apr; 13(1):46. PubMed ID: 29696513 [TBL] [Abstract][Full Text] [Related]
59. Age at attainment of peak bone mineral density and its associated factors: The National Health and Nutrition Examination Survey 2005-2014. Xue S; Kemal O; Lu M; Lix LM; Leslie WD; Yang S Bone; 2020 Feb; 131():115163. PubMed ID: 31760214 [TBL] [Abstract][Full Text] [Related]
60. The lipid accumulation product is a powerful tool to diagnose metabolic dysfunction-associated fatty liver disease in the United States adults. Li H; Zhang Y; Luo H; Lin R Front Endocrinol (Lausanne); 2022; 13():977625. PubMed ID: 36407325 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]